| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.28 | 3e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |